Pulsenmore Ltd. (PLSM)

NASDAQ: PLSM · Real-Time Price · USD
5.60
-0.20 (-3.45%)
Feb 11, 2026, 1:29 PM EST - Market open
Market Cap37.48M -39.1%
Revenue (ttm)2.76M +14.8%
Net Income-13.06M
EPS-2.04
Shares Out 6.43M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,362
Open5.79
Previous Close5.80
Day's Range5.65 - 5.79
52-Week Range5.56 - 10.28
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateMar 27, 2026

About PLSM

Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient’s smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel. [Read more]

Sector Healthcare
Founded 2014
Employees 58
Stock Exchange NASDAQ
Ticker Symbol PLSM
Full Company Profile

Financial Performance

In 2024, Pulsenmore's revenue was 9.66 million, an increase of 56.12% compared to the previous year's 6.19 million. Losses were -36.74 million, -37.28% less than in 2023.

Financial numbers in ILS Financial Statements

News

Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance

OMER, Israel, Feb. 9, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a new commercial engagement with TLC Perinatal PA, a ma...

2 days ago - PRNewsWire

Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center

OMER, Israel, Feb. 2, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in ...

9 days ago - PRNewsWire

Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation

Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month pilot; Service to be deployed via Beilinson NEXT, Beilinson's virtual hospital RAMAT GAN, Israe...

16 days ago - PRNewsWire

Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.

RAMAT GAN, Israel, Jan. 21, 2026 /PRNewswire/ -- Pulsenmore Ltd.  (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that its shares will begin trading on Nasdaq at ...

21 days ago - PRNewsWire